Skip to main content
Clinical Trials/IRCT20220823055784N1
IRCT20220823055784N1
Recruiting
Phase 2

Evaluation of the additive effect of transcranial direct current stimulation (tDCS)and Haboshefa in combination with conventional non-pharmacological therapies in reducing the temptation ,improvement of cognitive ability and stress in cannabis users.

Shahed University0 sites80 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahed University
Enrollment
80
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Presence of cannabis abuse criteria at least for 6 months
  • Absence of any other obvious psychiatric disorder such as bipolar or etc.
  • Age between 20 and 40
  • Male gender

Exclusion Criteria

  • Presence of underlying medical disease such as diabetes or malignancy or hypertension
  • Any other drug abuse

Outcomes

Primary Outcomes

Not specified

Similar Trials